GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » FCF Margin %

Gubra AS (CHIX:GUBRAC) FCF Margin % : -41.81% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Gubra AS's Free Cash Flow for the six months ended in Dec. 2023 was kr-43.1 Mil. Gubra AS's Revenue for the six months ended in Dec. 2023 was kr103.2 Mil. Therefore, Gubra AS's FCF Margin % for the quarter that ended in Dec. 2023 was -41.81%.

As of today, Gubra AS's current FCF Yield % is -1.13%.

The historical rank and industry rank for Gubra AS's FCF Margin % or its related term are showing as below:

CHIX:GUBRAc' s FCF Margin % Range Over the Past 10 Years
Min: -29.57   Med: 10.04   Max: 24.02
Current: -29.57


During the past 5 years, the highest FCF Margin % of Gubra AS was 24.02%. The lowest was -29.57%. And the median was 10.04%.

CHIX:GUBRAc's FCF Margin % is ranked better than
66.48% of 1044 companies
in the Biotechnology industry
Industry Median: -141.025 vs CHIX:GUBRAc: -29.57


Gubra AS FCF Margin % Historical Data

The historical data trend for Gubra AS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS FCF Margin % Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
- 14.97 24.02 5.11 -29.57

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Margin % Get a 7-Day Free Trial - 49.48 -37.51 -17.16 -41.81

Competitive Comparison of Gubra AS's FCF Margin %

For the Biotechnology subindustry, Gubra AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Gubra AS's FCF Margin % falls into.



Gubra AS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Gubra AS's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-60.615/205.005
=-29.57 %

Gubra AS's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-43.139/103.188
=-41.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gubra AS FCF Margin % Related Terms

Thank you for viewing the detailed overview of Gubra AS's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (CHIX:GUBRAC) Business Description

Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (CHIX:GUBRAC) Headlines

No Headlines